The IDCBIS has highly trained human talent with knowledge in advanced cell therapy, currently has a unit called Advanced Therapies Unit (UTA) responsible for research and development of stem cell-based products for use at pre-clinical scale and in clinical trials. The ATU promotes the generation of knowledge and innovation in biomedical sciences through the articulation of actors in science and technology (public sector, academia and industry).